Most of the interactions that have been documented with alprazolam are with medications that modulate CYP3A4 activity. Compounds that are inhibitors or inducers of CYP3A will be envisioned to extend or reduce plasma alprazolam concentrations, respectively. Drug products which have been analyzed in v